Notice ID: 1cc125a7a02d86bd62b6d06b223e11bbCombined Synopsis/Solicitation
2019 Vaccines for Adults
Archived on January 1, 2022. Original response deadline: . Full description on SAM.gov.
Overview
- Response deadline
- 5:00 PM UTC−05:00
- Posted
- June 25, 2019
- Notice type
- Combined Synopsis/Solicitation
- NAICS
- 325412: Pharmaceutical Preparation Manufacturing
Notice details
- PSC
- 65: MEDICAL/DENTAL/VETERINARY EQPT/SUPP
- Last updated
- Jan 23, 2026
Identifiers
- Solicitation number
- 75D301-19-R-67894
- Notice ID
- 1cc125a7a02d86bd62b6d06b223e11bb
Description
AWARD NOTICE: Contract Award of 6 Centers for Disease Control Vaccine for Adults (VFA) Contracts: 200-2019-05105 - Merck Sharp & Dohme Corp Award Amount: $86,407,050.00 200-2019-05106 - Sanofi Pasteur Inc. Award Amount: $36,351,538.70 200-2019-05107 - Dynavax Technologies Corporation Award Amount: $26,156,250.00 200-2019-05108 - GlaxoSmithKline LLC Award Amount: $112,644,450.00 200-2019-05109 - Grifols, USA Award Amount: $1,602,700.00 200-2019-05110 - Pfizer Inc. Award Amount: $46,031,000.00 This is a firm-fixed price, indefinite delivery/indefinite quantity delivery contract for the purchase of standard commercial vaccines described herein, manufactured under a current establishment and product license issued by the U.S. Food and Drug Administration. The period of performance is 7/1/2019 - 6/30/2020.
Award Overview
No prior contract identified
No matching prior contract was found within an 18-month window using the same agency, NAICS, place-of-performance state, and PSC. This may be a new requirement, or the prior award uses a different classification.
Contacts
Documents
Select documents to download
Showing 2 of 2 items
Document | Source | Agency | Posted Date | File Size | Actions | |
|---|---|---|---|---|---|---|
| Combined Synopsis/Solicitation | SAM.gov | Jun 25, 2019 | - | |||
| Combined Synopsis/Solicitation | SAM.gov | Jun 25, 2019 | - |
Lifecycle
Solicitation:
75D301-19-R-67894- Combined Synopsis
- 3×Combined SynopsisCurrentMar 25, 2019
2019 Vaccines for Adults
Similar Opportunities
Title | Phase | Deadline |
|---|---|---|
Emergency Pharmacy Order of DigiFAB | Sole Source / J&A | Open |
PRE-SOLICITATION NOTICE: The VA National Acquisition Center intends to issue a Request for Proposal (RFP) 36E79727R0010 for an unrestricted procurement for Nitroglycerin Patches, for the Department of Veterans Affairs (VA) (inclusive of Consolidated Mail Order Pharmacies (CMOPs) and Option 2 State Veterans Homes (SVH)), Department of Defense (DoD), Bureau of Prisons (BOP), Indian Health Service (IHS), and Federal Health Care Center (FHCC). VA will award one contract to the responsible offeror who will be able to provide an uninterrupted source of supply for the contracted items. The contract period will be for one year plus four pre-priced one-year option periods. The contract items will be distributed through the VA s and DoD s respective Pharmaceutical Prime Vendor Programs. Offerors must state the exact name (name that appears on label) by which the drug will be supplied and have an NDC number that is unique to the offeror. The successful offeror/contractor's label with its unique NDC shall be the only label on the product. Contractors shall not affix their label over another label on the product. VA labels must be able to securely adhere over the successful offeror/contractor's label. This product does not require unit of use packaging, as identified in the Schedule of Supplies. Patches must be boxed and must contain the bar code. The outside box as well as the patch must be barcoded. Solicitation #36E79727R0010 will be electronically issued in commercial item format in accordance with FAR Part 12 on or about December 1, 2026, with a tentative closing date of December 15, 2026. The NAICS code for this procurement is 325412. Any future amendments and other miscellaneous documents will be available electronically for download at SAM.gov. No paper copies of the solicitation will be available, and no telephone requests for paper copies of the solicitation will be accepted. Interested offerors are advised to continuously check Contracting Opportunities at SAM.gov for any changes to this solicitation. All responsible sources may submit an offer that if timely received, will be considered. The point of contact for this procurement is Jacob Werling. Questions can be e-mailed to Jacob.Werling@va.gov. The estimated annual requirements are as follows: REQUIREMENT DESCRIPTION ITEM DESCRIPTION UNIT of USE PKG. SIZE (Patches per Box) TOTAL EST. ANNUAL USAGE (Boxes) 1 Nitroglycerin 0.1 mg Patch N 30 4,982 2 Nitroglycerin 0.2 mg Patch N 30 10,044 3 Nitroglycerin 0.4 mg Patch N 30 8,720 4 Nitroglycerin 0.6 mg Patch N 30 2,213 | Pre-Solicitation | 11/18/2026 |
PRE-SOLICITATION NOTICE: The VA National Acquisition Center intends to issue Request for Proposal (RFP) 36E79727R0009 for an unrestricted procurement for MULTIVIT/OPHTH AREDS2/LUTEIN/ZEAXANTHIN CAP/TAB, for the Department of Veterans Affairs (VA) (inclusive of Consolidated Mail Order Pharmacies (CMOPs) and Option 2 State Veterans Homes (SVH)), Department of Defense (DoD), Bureau of Prisons (BOP), Indian Health Service (IHS), and Federal Health Care Center (FHCC). VA will award one contract to the responsible offeror who will be able to provide an uninterrupted source of supply for the contracted items. The contract period will be for one year plus four pre-priced one-year option periods. The contract items will be distributed through the VA s and DOD s respective Pharmaceutical Prime Vendor Programs. Offerors must state the exact name (name that appears on label) by which the drug will be supplied and have an NDC number that is unique to the offeror. The successful offeror/contractor's label with its unique NDC shall be the only label on the product. Contractors shall not affix their label over another label on the product. Solicitation #36E79727R0009 will be electronically issued in commercial item format in accordance with FAR Part 12 on or about December 23, 2026, with a tentative closing date of January 13, 2027. The NAICS code for this procurement is 325412. Any future amendments and other miscellaneous documents will be available electronically for download at sam.gov. No paper copies of the solicitation will be available, and no telephone requests for paper copies of the solicitation will be accepted. Interested offerors are advised to continuously check Contracting Opportunities at SAM.gov for any changes to this solicitation. All responsible sources may submit an offer that if timely received, will be considered. The point of contact for this procurement is Chris Carthron. Questions can be e-mailed to Christopher.Carthron@va.gov. The estimated annual requirements are as follows: REQUIREMENT DESCRIPTION ITEM DESCRIPTION PACKAGE SIZE (Bottles) TOTAL ESTIMATED ANNUAL USAGE (Bottles) 1 MULTIVIT/OPHTH AREDS2/LUTEIN/ZEAXANTHIN CAP/TAB 120 829,230 | Pre-Solicitation | Open |
Please see attached documents. | Pre-Solicitation | 12/15/2026 |
Department of Veterans Affairs Pharmaceutical Prime Vendor 2028 Specialty Pharmacy RFI AMENDMENT 0002 The purpose of this amendment is to extend the response date for this Request for Information (RFI) from November 16, 2026, 11:00 AM Central Time to November 30, 2026, 11:00 AM Central Time. All other information in this notice, including Amendment 0001, remains unchanged. | Market Research | 11/30/2026 |
Additional Details
Solicitation Number
75D301-19-R-67894
Archive Date
Jan 1, 2022